| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000266717.1 |
Vinorelbine |
Breast invasive carcinoma |
0.019631808 |
Resistant |
| ENSG00000266717.1 |
Vinorelbine |
Bladder urothelial carcinoma |
0.048347953 |
Sensitive |
| ENSG00000266717.1 |
Vinorelbine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005743761 |
Sensitive |
| ENSG00000266717.1 |
Vinorelbine |
Colon adenocarcinoma |
0.007256602 |
Sensitive |
